Odd Lots
Odd Lots

How the Number One U.S. Semiconductor Company Stumbled

For years, Intel has been the pre-eminent U.S. semiconductor company. But lately, the company has stumbled. This past summer, shares in the company plunged after it said it was experiencing delays in the production of its next generation chips. And while most tech companies have been on an absolute

Featured Speakers

Bloomberg HostStacey Rasgen Guest

Topics Discussed

Episode Summary

Executive Summary: The episode examines Intel’s mounting manufacturing troubles and what they mean for the semiconductor industry, stock valuation, and U.S. tech strategy. Bernstein analyst Stacey Rasgen argues Intel’s 10nm and 7nm delays reflect deep, compounding execution issues, not isolated setbacks, and that the company’s integrated model is losing ground to fabless rivals and TSMC-led foundry manufacturing.

Main Topics: Intel’s manufacturing breakdown (Priority: 5/5): Discussion of Intel’s repeated delays at 14nm, 10nm, and now 7nm, with Rasgen arguing the problems have accumulated over years and now threaten the company’s competitive position. Meaning of nanometer nodes and Moore’s Law (Priority: 4/5): Rasgen explains that node names are largely marketing labels, while the real issue is transistor density, performance, power efficiency, and rising cost as Moore’s Law slows. Intel IDM model vs. fabless/foundry model (Priority: 5/5): The conversation contrasts Intel’s integrated design-and-manufacturing approach with the fabless-foundry ecosystem led by TSMC, arguing the latter now has structural advantages. Market reaction and valuation risk (Priority: 5/5): Intel’s stock drop after the 7nm disclosure is framed as a thesis-changing event because investors can no longer confidently model Intel’s future competitiveness. AMD, Apple, and competitive erosion (Priority: 4/5): AMD’s rise and Apple’s shift away from Intel underscore how Intel is losing share across PCs and servers as rivals gain process and design advantages. Geopolitics and U.S. semiconductor policy (Priority: 4/5): The episode broadens into strategic concerns about dependence on Taiwan and the importance of domestic semiconductor capacity for U.S. national security. Possible restructuring and policy support (Priority: 3/5): Rasgen discusses Intel potentially outsourcing more leading-edge production and says U.S. policy help could support the industry, though it won’t solve Intel’s technical problems.

Key Arguments: Intel’s problems are not new; 10nm was delayed for years and 7nm represents another, more severe credibility shock. Nanometer labels are not directly comparable across firms; the real economic issue is whether each new node delivers better density, performance, and cost. Intel’s integrated device manufacturer model once helped it differentiate, but now manufacturing failures are undermining both product delivery and design planning. TSMC’s foundry model benefits from scale by aggregating demand across many chip designers, making it structurally more resilient. The 7nm setback matters more than earlier delays because investors had been told the issue was under control, so confidence in Intel’s roadmap collapsed. AMD’s momentum and Apple’s transition away from Intel show that competitive losses are becoming tangible, not hypothetical. If Intel becomes increasingly fab-light, it may remain a large and profitable company, but it would lose its unique process leadership and likely trade like a slower-growing industrial tech company. U.S. policymakers should care because leading-edge chipmaking is concentrated in only a few firms, with Taiwan becoming strategically critical. Throwing money at Intel alone will not fix its engineering issues, though broader semiconductor investment and incentives could help the ecosystem.

Data Points: Intel 7nm delay: 12 months - Intel said its 7nm process was delayed by about a year after disclosing the issue in July. Intel 7nm product delay: 6 months - Rasgen noted Intel said products tied to the prior roadmap were delayed about six months. Intel 10nm delay: 5-6 years - He described 10nm as a multi-year manufacturing failure that forced Intel to stay on 14nm far longer than planned. 14nm delay: ~1 year - Even Intel’s 14nm node reportedly took about a year longer than anticipated to reach full manufacturable yields. Intel process density jump at 10nm: 2.7x - Rasgen said 10nm aimed for a much larger density increase than normal, contributing to technical difficulty. Typical node density jump: 2.2x-2.4x - He contrasted 10nm with the usual increase for a node transition. Intel 7nm density jump: 1.7x - He said 7nm was designed as a smaller, corrective step after the 10nm debacle. Lithography wavelength: 193 nanometers - Rasgen used this to illustrate how advanced chipmaking prints features far smaller than the light used. Intel employees: 113,000 - Used to underscore Intel’s scale and why its problems are surprising. Intel annual R&D spend: $13 billion+ - He cited Intel’s heavy spending to show that the company’s problems are not due to lack of resources. Intel free cash flow: ~$18 billion+ - Rasgen said Intel still generates substantial cash despite its decline. Intel earnings this year: ~$5/share - He noted that Intel remains profitable even amid its manufacturing issues. AMD stock low point: below $2 - He referenced AMD’s past distress to show how far the company has recovered. AMD stock level: close to $80 - He used AMD’s rise to illustrate the company’s improving competitive position. Leading-edge manufacturers: 3 companies - Rasgen said only Intel, Samsung, and TSMC still do leading-edge semiconductor manufacturing. TSMC Arizona fab: 20,000 wafers per month - He described the Arizona fab as symbolically important but economically modest. TSMC Arizona investment: $12 billion over 8 years - He said the planned U.S. fab investment is small relative to the scale of the industry. U.S. semiconductor funding ambition: $28-30 billion - He referenced proposed U.S. initiatives as too small to create a full industrial rebasing.

Pivotal Quotes: "These are not new issues." — Stacey Rasgen: He emphasized that Intel’s current 7nm problems are part of a long-running pattern, not a one-off setback. "Their credibility on this stuff is now zero." — Stacey Rasgen: He explained why Intel’s repeated roadmap misses have severely damaged investor trust. "We need an Apollo moment." — Stacey Rasgen: He argued that meaningful U.S. semiconductor rebuilding would require far larger public investment than currently proposed.

Implications: Intel may remain profitable, but its role as a process leader is in jeopardy. If it outsources more, the U.S. becomes more dependent on Taiwan and TSMC, raising both valuation uncertainty and national-security concerns.

🔓 Sign Up for Unlimited Episode Search

About Odd Lots

Bloomberg's Joe Weisenthal and Tracy Alloway analyze the weird patterns, the complex issues and the newest market crazes. Join the conversation every Tuesday and Thursday for interviews with the most interesting minds in finance, economics and markets.

View all episodes from Odd Lots